ANORO ELLIPTA Inhalation Powder Keňa - angličtina - Pharmacy and Poisons Board

anoro ellipta inhalation powder

glaxosmithkline pharmaceutical kenya limited p.o. box 78392-00507, likoni road industrial - umeclidinium bromide and vilanterol trifenatate - inhalation powder - 62.5mcg/25mcg - vilanterol and umeclidinium bromide

ANORO ELLIPTA INHALATION POWDER 62.5 MCG25 MCG Singapur - angličtina - HSA (Health Sciences Authority)

anoro ellipta inhalation powder 62.5 mcg25 mcg

glaxosmithkline pte ltd - (umec strip) umeclidinium bromide (micronised) 74.2 mcg/dose eqv umeclidinium; (vi strip) vilanterol trifenatate (micronised) 40 mcg/dose eqv vilanterol - powder, metered - (umec strip) umeclidinium bromide (micronised) 74.2 mcg/dose eqv umeclidinium 62.5 mcg/dose; (vi strip) vilanterol trifenatate (micronised) 40 mcg/dose eqv vilanterol 25 mcg/dose

SPIOLTO RESPIMAT Izrael - angličtina - Ministry of Health

spiolto respimat

boehringer ingelheim israel ltd. - olodaterol as hydrochloride; tiotropium bromide as monohydrate - solution for inhalation - olodaterol as hydrochloride 2.5 mcg; tiotropium bromide as monohydrate 2.5 mcg - vilanterol and umeclidinium bromide - spiolto respimat is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).

INCRUSE ELLIPTA POWDER Kanada - angličtina - Health Canada

incruse ellipta powder

glaxosmithkline inc - umeclidinium (umeclidinium bromide) - powder - 62.5mcg - umeclidinium (umeclidinium bromide) 62.5mcg - antimuscarinics antispasmodics

INCRUSE ELLIPTA umeclidinium (as bromide) 62.5 microgram powder for inhalation Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

incruse ellipta umeclidinium (as bromide) 62.5 microgram powder for inhalation

glaxosmithkline australia pty ltd - umeclidinium bromide, quantity: 74.2 microgram (equivalent: umeclidinium, qty 62.5 microgram) - inhalation, powder for - excipient ingredients: magnesium stearate; lactose monohydrate - incruse ellipta is indicated as a long term once daily maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd)